Hyperuricemia and Left Ventricular Diastolic Function
Associations and Plausibility Among Left Ventricle Diastolic Function, Serum Uric Acid and Inflammatory Biomarkers in Individuals With Cardiometabolic Risks - A Prospective Observational Study
Sponsor: National Defense Medical Center, Taiwan
Terminated
The study interest was reached
Other Hyperuricemia trials with similar outcome
This observational or N/A phase trial investigates Hyperuricemia and Left Ventricular Diastolic Dysfunction and is currently terminated or withdrawn. National Defense Medical Center, Taiwan leads this study, which shows 7 recorded versions since 2017 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
-
Jan 2021 — Dec 2021 [monthly]
Terminated
-
Nov 2020 — Jan 2021 [monthly]
Terminated
▶ Show 2 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Terminated
-
May 2018 — Jun 2018 [monthly]
Terminated
First recorded
Aug 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Defense Medical Center, Taiwan
For direct contact, visit the study record on ClinicalTrials.gov .